The Times-Tribune
Alan L. is sounding the alarm on how PBMs and opaque insurance practices are driving up prescription drug costs: operating in the shadows without accountability, inflating prices through a lack of transparency, and putting profits over patients. Alan is urging Congress to pass meaningful PBM reform rather than adopting foreign pricing models, arguing that fixing the middleman system is the key to lowering costs.